Published on : Jan 08, 2019
Albany, New York, January 8, 2019: Diagnostic deals associated with Alzheimer’s disease and contagious disease, namely Zika virus have signified the importance of diagnostic partnering in oncology. In 2017, genetic technology became the kingpin for the oncology diagnostic related acquisition. In a bid to strengthen its health care offerings through expansion, a deal partly funded by Japan’s public/private Innovation Network Corporation witnessed Konica Minolta Inc. agreeing to pay USD 800 million in cash along with up to USD 200 million in earn-outs for Ambry Genetic Corp., a privately held genetic testing firm.
This breakthrough diagnostic deal making will open avenue for diagnostic technologies for drug discovery and oncology and at the same time provide Japan an exhaustive genetic diagnostic portfolio. These excerpts can be found in the report titled, “Global Diagnostics Partnering 2010-2018: Deal trends, players, financials and forecasts,” which has been lately incorporated in the expanding repository of Market Research Hub (MRH).
Artificial Intelligence is estimated to remain bullish in the pharmaceutical and medical device industries. For instance, MySugr GMBH was recently acquired by Roche to augment its diagnostic division as it provided the latter company with set of services and applications that combine therapy management, diabetes coaching, automated data tracking to mix with its own services and glucose monitoring systems.
The pioneer of liquid biopsy technology merged with China based Cirina Ltd., which is specifically focused on detection of early-stage cancer using blood related markers.
The past few years have witnessed a significant rise in the diagnostic partnering and deals which could be attributed to the transpiring science producing robust diagnostics biomarkers and providing layer to augment precision medicines. This is the opportune time to harness new business models.
Diagnostic Partnering: Report Content
The report provides a comprehensive assessment on the diagnostic partnering through qualitative and quantitative assessment of the market. The report also delves into drivers, opportunities, trends and restraints which have significant impact on the growth of diagnostic partnering and deals. The report also incorporates assessment of partnering resource center such as online partnering, partnering events and further reading on deal making.
The report includes diagnostic deal making on the basis of technology type, stage of development, deal type, and therapy type. The report incorporates diagnostic deals with an upfront value, headline value, milestone value and royalty value. The readers will get a holistic picture through this report as it will also give insights on the future partnering events.
The report begins with exhaustive executive summary followed by trends in diagnostic deal making. Further, the report delves into most active deal makers and gives introduction on leading diagnostic deals.
Diagnostic Partnering: Research Methodology
The research methodology applied in this report includes secondary research, primary research and review from expert panel. The secondary sources incorporate company websites, national government documents, annual reports, SEC filings, internal and external proprietary database, industry white paper, World Bank database, market reports, regulatory database and statistical database. Whereas, primary sources incorporate face to face interview, e-mail interactions and telephonic interviews. In order to provide readers with an unbiased report, expert panel extensively reviews the report on diagnostic partnering.
Request a Sample with TOC in a PDF format : https://www.marketresearchhub.com/enquiry.php?type=S&repid=1988907
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients
For Enquiries, Call :
+1-800-998-4852US Toll Free
Email : firstname.lastname@example.org